1. Introduction

Biohacking Criminal Prosecution Law in Russia concerns the criminal liability of individuals, researchers, biotechnology companies, medical practitioners, laboratories and private biohackers who use biological, genetic, neurological or biomedical technologies in ways that violate Russian criminal law.

Biohacking may involve:

Genetic modification and gene editing (including CRISPR).

DIY biology and experimental biotechnology.

Human biological enhancement and implantation.

Unauthorised administration of experimental substances.

Genetic testing and manipulation of biological samples.

Neural implants and neurological experimentation.

Human-cell engineering and synthetic biology.

Unauthorised biological experimentation and potentially dangerous pathogen research.

Important legal distinction: Russia does not have one comprehensive criminal offence called biohacking. Criminal prosecution depends on the particular conduct, the harm caused, the intention of the accused and the applicable provisions of the Russian Criminal Code.

Consequently, a biohacker may be prosecuted under existing offences relating to bodily injury, illegal medical practice, public health, biological safety, unlawful drug circulation, privacy violations or environmental harm.

2. Russian Legal Framework

The principal legislation governing biohacking-related criminal liability includes the following:

The principal statutory framework is the Russian Criminal Code, supplemented by biotechnology, healthcare and biological-safety legislation.

Consultant Plus+3

3. Major Criminal Offences Applicable to Biohackers

A. Article 235 – Illegal Medical or Pharmaceutical Activity

This is one of the most relevant provisions for biohacking prosecutions.

It applies where a person performs medical or pharmaceutical activities without a licence when licensing is legally required, and the activity negligently causes harm to human health.

Examples:

A biohacker performs an unauthorised gene-therapy procedure.

An unlicensed practitioner injects experimental biological substances into a person.

A private laboratory offers unauthorised medical enhancement treatments.

An individual performs experimental implantation procedures without the required authorisation.

Punishment:

Part 1: A fine of up to 120,000 roubles, restriction of liberty, compulsory labour or imprisonment for up to three years.

Part 2: Where the conduct negligently causes death, compulsory labour or imprisonment for up to five years.

Importantly, merely experimenting without a licence does not automatically establish Article 235. The prosecution must establish the required medical activity, licensing obligation, health consequences and causal connection.

Consultant Plus+1

B. Article 111 – Intentional Infliction of Serious Bodily Harm

Article 111 becomes relevant when a biohacker intentionally causes serious physical injury.

Examples include:

Deliberately administering a harmful experimental substance.

Performing dangerous implantation procedures knowing that serious injury will result.

Intentionally causing permanent biological damage.

Carrying out non-consensual physical or biological interventions.

Depending on the circumstances and aggravating factors, imprisonment can reach 15 years.

The central issue is whether the prosecution can establish the required intention and seriousness of the injury.

C. Article 118 – Causing Serious Harm Through Negligence

This provision may apply when a biohacker causes serious bodily injury without intending that result.

Examples:

Incorrect administration of experimental substances.

Negligent handling of biological implants.

Failure to follow essential safety procedures.

Inadequate monitoring after an experimental intervention.

Article 118 distinguishes negligent injury from intentional bodily harm under Article 111.

D. Article 236 – Violation of Sanitary and Epidemiological Rules

This provision is important for DIY biology laboratories and experimental biological facilities.

It may apply when violations of sanitary and epidemiological requirements negligently cause mass illness or poisoning.

Potential situations include:

Unsafe biological experimentation.

Improper handling of infectious materials.

Failure to follow applicable sanitation procedures.

Contamination affecting laboratory workers or members of the public.

The precise offence and penalty depend on the consequences and applicable part of Article 236.

UNIDIR Cyber Policy Portal Database+1

E. Article 238 – Services Not Meeting Safety Requirements

This provision may apply where a biohacking business provides services that do not meet legally established safety requirements.

Examples:

Selling dangerous biological enhancement procedures as safe treatments.

Providing unsafe experimental injections.

Concealing known health risks from customers.

Offering dangerous biomedical services through an unregulated commercial operation.

The prosecution must establish the statutory elements of the offence; an unsuccessful experiment or adverse medical outcome alone is insufficient.

F. Article 248 – Violation of Biological-Agent Safety Rules

Article 248 is particularly important for laboratories handling pathogenic biological agents.

It concerns violations of safety rules governing the handling of pathogenic biological agents where the statutory harmful consequences occur.

Potential situations include:

Unsafe handling of dangerous pathogens.

Accidental release of pathogenic biological material.

Negligent laboratory containment failures.

Failure to observe mandatory biological-safety procedures.

Important 2024 amendment: Federal Law No. 361-FZ of 29 October 2024 amended Article 248. It introduced a separate aggravated provision where negligent violations result in the deaths of two or more people, carrying imprisonment of up to eight years.

This is particularly relevant to high-risk DIY biology and bioengineering facilities.

Consultant Plus+1

G. Article 234 – Illegal Circulation of Potent or Toxic Substances

This provision may become relevant when biohackers illegally manufacture, acquire, store, transport or distribute substances covered by the statutory controls.

Examples include:

Unlawful distribution of controlled potent substances.

Illegal commercial circulation of certain toxic compounds.

Unauthorised distribution of substances used in experimental enhancement.

Not every experimental chemical or biological product falls within Article 234. Its legal classification must be examined against the applicable controlled-substance lists.

H. Article 137 – Violation of Privacy

Biohacking may involve the collection and processing of genetic information.

Article 137 may apply where legally protected private information is unlawfully collected or disseminated.

Examples include:

Publishing another person's genetic profile without lawful grounds.

Exposing confidential biological information.

Disclosing sensitive genetic information obtained through unauthorised testing.

The applicability of Article 137 depends on the nature of the information, the manner of collection or disclosure and the statutory elements of the offence.

4. Genetic Engineering and Biohacking Regulation

An important statute is Federal Law No. 86-FZ of 5 July 1996, concerning state regulation of genetically engineered activities.

It addresses genetic-engineering activities involving:

Recombinant DNA and RNA technologies.

Genetic manipulation at molecular and cellular levels.

Genetically modified microorganisms.

Transgenic plants and animals.

Genetic-engineering-modified organisms.

Article 12 establishes liability for individuals and legal entities whose actions or omissions cause harm to workers, the population or the environment.

However, Article 12 is not itself a standalone criminal offence. Criminal prosecution must be based on an applicable provision of the Criminal Code.

Consultant Plus+2

Human genetic experimentation

A particularly important legal distinction concerns genetic modification of human beings.

Federal Law No. 86-FZ principally regulates genetic engineering in relation to genetically modified organisms. Its scope does not comprehensively regulate genetic-engineering procedures applied to humans, tissues and cells as part of the human organism.

Consequently, human gene-editing activities may require analysis under other healthcare, consent, research and criminal-law provisions.

This creates a regulatory challenge: scientific innovation can develop faster than the specific criminal legislation designed to govern it.

5. Important Case Laws and Judicial Decisions

There is an important limitation in Russian biohacking jurisprudence: there is no established body of reported criminal judgments specifically prosecuting DIY human gene editing or modern biohacking as a separate offence.

Nevertheless, several decisions provide useful legal principles for analogous prosecutions.

Case 1. Matytsina v. Russia (2014)

Highly relevant precedent

Court: European Court of Human Rights.

Application: No. 58428/10.

Subject: Illegal medical practice under Article 235 of the Russian Criminal Code.

Facts:

The applicant and another individual provided various services under the description of training programmes. These included psychological adaptation, dietary therapy, medicinal gymnastics and psychotherapeutic treatment.

Russian domestic courts found that the activities constituted medical services requiring professional qualifications and licensing.

The applicant was convicted under Article 235.

Legal issues:

Whether the activities constituted medical practice.

Whether the licensing requirements were sufficiently clear.

Whether criminal liability could be imposed consistently with the principle of legality.

Whether the applicant could reasonably foresee that the conduct constituted a criminal offence.

Judgment and significance:

The European Court examined the lack of clarity in the relevant Russian regulatory framework and found a violation of Article 7 of the European Convention on Human Rights concerning the principle of legality.

Application to biohacking:

This judgment is important because a Russian biohacker cannot automatically be convicted merely because an activity is scientifically unconventional.

The prosecution must demonstrate that the activity falls within a sufficiently clear legal prohibition and that the accused could reasonably foresee the criminal consequences.

Source: Read the ECHR judgment.

HUDOC+1

Case 2. Moscow illegal medical activity prosecution (2026)

Authority: Moscow Prosecutor's Office.

Date: 7 April 2026.

Alleged offence: Article 235(2), Russian Criminal Code.

Facts:

According to the Moscow Prosecutor's Office, a 27-year-old woman was accused of conducting medical and cosmetic procedures without the necessary medical qualifications and licence.

Following procedures performed on a 38-year-old patient on 4 January 2026, the patient's health deteriorated and she subsequently died.

The prosecution alleged that the accused's unlicensed medical activity had negligently caused the death.

Legal significance:

This prosecution illustrates the application of Article 235(2) to unlicensed medical procedures.

It is relevant to commercial biohacking services involving:

Experimental injections.

Unauthorised biological enhancement.

Invasive cosmetic procedures.

Medical implantation.

Important: This was a reported criminal case sent to court, not a final conviction. The accused remains entitled to the presumption of innocence.

Source: Moscow Prosecutor's Office announcement.

Case 3. Russian GMO regulatory liability and judicial practice

Authority: Library of Congress, Law Library.

Subject: Restrictions on genetically modified organisms in Russia.

The Library of Congress examined Russia's GMO regulatory framework and identified administrative liability for various regulatory violations.

Its historical review reported that Russia had no significant judicial decisions shaping GMO regulatory practice at the time of publication.

Legal significance:

This research demonstrates the distinction between:

Administrative GMO violations.

Criminal biological-safety offences.

Criminal liability for actual injury or environmental damage.

It also highlights the absence of a mature body of GMO-specific criminal jurisprudence.

Source: Library of Congress – Restrictions on GMOs in Russia.

Case 4. Academic analysis of Article 235 prosecutions (2025)

Author: Elizaveta A. Nikulova.

Publication: Problems (Features) of Qualification of Illegal Medical Activity, 2025.

The research examines Russian judicial practice under Article 235 during 2020–2024.

It identifies difficulties in distinguishing illegal medical activity from:

Illegal entrepreneurship under Article 171.

Unsafe services under Article 238.

Negligently causing death under Article 109.

Negligently causing serious bodily injury under Article 118.

Application to biohacking:

This analysis is particularly useful when determining whether a private biohacking laboratory is providing medical services, conducting scientific research or operating an illegal commercial enterprise.

Source: Read the 2025 legal research.

6. Criminal Prosecution Procedure in Russia

A biohacking-related criminal prosecution generally follows the ordinary Russian criminal procedure.

Complaint or detection

Authorities may receive complaints from victims, medical institutions, laboratories or regulatory agencies.

Pre-investigation verification

Investigators examine the alleged conduct and determine whether there are grounds to initiate criminal proceedings.

Scientific and medical examination

Experts may examine biological samples, medical records, laboratory equipment, genetic data and the cause of injury.

Identification of the offence

Investigators determine whether Articles 111, 118, 235, 236, 238 or 248, or another provision, applies.

Investigation and prosecution

Evidence is collected, the suspect's procedural rights are respected and the case may be referred to the prosecutor and court.

Judicial determination

The court determines whether the prosecution has established the offence and whether the accused is guilty.

7. Evidence Required in Biohacking Criminal Cases

Scientific evidence is particularly important because biological experimentation can involve complicated causal relationships.

A critical issue is causation. Investigators must distinguish injuries caused by the experiment from pre-existing conditions, unrelated medical complications and other possible causes.

8. Criminal Liability of Individuals and Biotechnology Companies

Russian criminal law principally imposes criminal liability on natural persons rather than corporations.

Therefore, potential defendants may include:

Individual biohackers.

Laboratory directors.

Research scientists.

Medical practitioners.

Laboratory technicians.

Individuals organising unlawful experiments.

Managers or other employees who personally satisfy the elements of an offence.

A biotechnology company may face administrative and civil liability, while responsible individuals may face criminal prosecution.

Federal Law No. 86-FZ also expressly recognises liability of citizens and legal entities for harm resulting from genetic-engineering activities.

Контур.Экстерн+1

9. Major Legal Challenges

9.1 Absence of a specific biohacking offence

The Russian Criminal Code does not establish one comprehensive offence covering all forms of biohacking.

This creates uncertainty when distinguishing scientific experimentation from unlawful medical activity.

9.2 Human genome modification

Criminal law must address the difficult question of how existing offences apply to unauthorised human genetic modification, particularly where no immediate physical injury occurs.

9.3 Informed consent

A signed consent form does not automatically legalise an otherwise prohibited medical intervention.

Courts must examine whether consent was informed, voluntary and legally effective.

9.4 Scientific uncertainty

Genetic modification may produce delayed or unpredictable consequences.

Prosecutors may face difficulties proving causation between a particular experiment and subsequent disease or injury.

9.5 Cross-border biohacking

A Russian biohacker may obtain biological materials, equipment or experimental substances from foreign suppliers.

Such activities can raise additional questions involving customs, pathogenic-agent controls, international cooperation and jurisdiction.

9.6 Corporate accountability

A company may organise an experimental programme while individual employees carry out its procedures.

Determining which individuals possessed the necessary knowledge, authority and involvement is therefore essential.

10. Hypothetical Criminal Prosecution Examples

These are possible legal classifications, not automatic outcomes. Each prosecution requires proof of the elements of the relevant offence.

11. Recommendations for Legal Reform in Russia

Several reforms could improve the regulation of biohacking:

Introduce clearer statutory definitions of human biohacking and experimental biological interventions.

Establish specific rules for non-therapeutic human genetic enhancement.

Clarify criminal liability for unauthorised human genome modification.

Strengthen informed-consent protections for experimental participants.

Establish specialised biological-safety investigation procedures.

Improve accountability for commercial DIY biotechnology laboratories.

Introduce clear rules governing genetic-data collection and disclosure.

Strengthen cross-border cooperation concerning dangerous biological materials.

12. Conclusion

Biohacking Criminal Prosecution Law in Russia is an emerging area of legal analysis involving criminal law, biotechnology, medical regulation, genetic privacy and biological safety.

The most important statutory provisions include Articles 111, 118, 137, 234, 235, 236, 238 and 248 of the Russian Criminal Code.

Three important conclusions emerge:

First: Biohacking is not automatically a criminal offence in Russia. The prosecution must establish an offence defined by existing legislation.

Second: Article 235 is particularly important when unlicensed medical or pharmaceutical activities cause injury or death.

Third: Article 248 provides an important mechanism for prosecuting violations of pathogenic biological-agent safety rules, including particularly serious consequences.

The Matytsina v. Russia judgment is especially important because it demonstrates that criminal prosecution must respect legal certainty and the principle that criminal offences must be sufficiently foreseeable.

Overall, Russian law regulates dangerous biohacking primarily through existing criminal offences rather than a dedicated biohacking criminal statute.

13. Important Legal References

Russian Criminal Code, Federal Law No. 63-FZ.

Federal Law No. 86-FZ – Genetic Engineering.

Federal Law No. 492-FZ – Biological Safety.

Federal Law No. 361-FZ of 2024 – Biological-Agent Safety Amendments.

Matytsina v. Russia – ECHR Judgment.

Moscow Prosecutor's Office – 2026 Prosecution Announcement.

Library of Congress – Russian GMO Regulatory Framework.

Research note: This is an academic legal explanation, not an opinion on a particular criminal case. The statutory position should be checked against the official Russian text and amendments applicable on the date of the alleged conduct.